Using X-tile software, we determined the cut-off values for EPSTI1 and CXCL11 expression levels, respectively, and divided patients in the GSE39582 and TCGA-COAD cohorts into groups with high and low expression levels of the corresponding genes. The gene discussed is EPSTI1; the disease is colon adenocarcinoma.